BrainStorm Cell Therapeutics
BCLI
#10443
Rank
C$14.07 M
Marketcap
C$1.28
Share price
1.10%
Change (1 day)
17.91%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -C$15.27 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$16.13 Million, an increase over its 2023 earnings that were of -C$23.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$15.27 Million-5.28%
2024 -C$16.13 Million-32.39%
2023 -C$23.85 Million-29.18%
2022 -C$33.68 Million-0.74%
2021 -C$33.92 Million-23.12%
2020 -C$44.12 Million36.8%
2019 -C$32.25 Million66.71%
2018 -C$19.35 Million181.66%
2017 -C$6.87 Million-0.6%
2016 -C$6.91 Million-41.31%
2015 -C$11.78 Million-8.22%
2014 -C$12.83 Million89.74%
2013 -C$6.76 Million42.27%
2012 -C$4.76 Million-12.45%
2011 -C$5.43 Million63.04%
2010 -C$3.33 Million35.52%
2009 -C$2.46 Million-48.99%
2008 -C$4.82 Million-44.39%
2007 -C$8.66 Million
2005 -C$4.49 Million-91.44%
2004 -C$52.4 Million94007.62%
2003 -C$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
C$2.15 B-14,450.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.58 B-90,428.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-C$1.1 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-C$1.09 Billion 7,137.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$28.65 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-C$0.36 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA